Research Indication definition

Research Indication means an Indication for which Products are being developed under the Research Program prior to achievement of the Acceptance Criteria. The initial Research Indications are listed in Exhibit E attached hereto, which shall be updated by the Parties as Research Indications are added or removed.
View Source
Research Indication means each of: (a) Muscle Diseases; (b) ***, in the event GSK expands the Research Program into ***; and (c) any Other Indication agreed upon by the Parties pursuant to Section 3.3.2(c).
View Source

Examples of Research Indication in a sentence

  • Upon achievement of the Acceptance Criteria for a Product for a specific Research Indication, Licensee may elect, by providing Penn with formal written notice, to convert such Research Indication to a Licensed Indication within [***], provided, however, that Licensee shall not be obligated to make an election decision for more than one (1) Research Indication in any [***] time period following the achievement of the Acceptance Criteria for the first Product as determined by the JSC [***].

  • During the Research Term, on a Research Indication-by-Research Indication basis, the JSC shall determine if the Acceptance Criteria have been achieved for a Product for such Research Indication.

  • FivePrime may research and develop such Reverted Target for any indication (including the Reverted Target Research Indication) in connection with a FivePrime internal program during the Research Program Term, but shall not license to a Third Party any rights with respect to such Reverted Target in the Reverted Target Research Indication until the expiration of the Research Program Term (the “FivePrime Reverted Target Exclusivity Period”).

  • If, however, GSK elects not to exercise its Claiming Option with respect to such Hit, then such Hit shall not be deemed a Reverted Target as that term is defined herein but rather shall thereafter be referred to as a “Non-Selected Target” and such Non-Selected Target shall be considered outside of the scope of this Agreement and the Research Program with respect to the particular Research Indication for which the Hit was identified by FivePrime.

  • Each Party shall establish, for each Research Indication, a team (the “Project Team”) that shall work together with the other Party’s Project Team to form a single group (each, a “Working Group”) that is responsible for carrying out the activities under the Research Plan for such Research Indication.

  • Each Working Group for a particular Research Indication shall make decisions on day-to-day operational matters, make decisions on which Hits shall be subject to further assays to confirm selection of such Hits as Offered Hits, as provided in Section 3.4.1(b), and conduct the activities under the Research Plan, in each case for such Research Indication.

  • Subject to Section 2.2.4, each Party shall conduct activities allocated to it under the Research Plan for each Research Indication.

  • Upon receipt of such notice of termination for any Research Program for any Research Indication, FivePrime shall use reasonable efforts to wind down the efforts expended by FivePrime on such Research Program for such Research Indication, and GSK shall remain responsible for all liabilities and obligations incurred or accrued as provided in Section 6.2 for a terminated Research Program with respect to a particular Research Indication prior to the effective date of such termination.

  • GSK and FivePrime each shall appoint a member of its respective Project Team(s) (each, a “Project Leader”), who shall be responsible for coordinating the Research Program for his/her own Project Team and the Working Group focusing on a particular Research Indication.

  • Each Working Group for a particular Research Indication shall also serve as a forum through which the Parties will share day-to-day operational information regarding the Research Program for such Research Indication, all in accordance with the terms of this Agreement.